Furthermore, AL101 is well tolerated in vivo and has significant antitumor effects in ACC patient-derived xenograft (PDX) models with NOTCH1 activating mutations, but not in PDX models with WT NOTCH genes. The gene discussed is NOTCH1; the disease is adrenal cortex carcinoma.